Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FR05R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,611
Award facts
- Contract value 100% obligated
- $28,610.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,610.67 to AmerisourceBergen Drug Corp for supply of Vraylar 1.5 mg capsules (30-count units). This firm fixed-price delivery order, issued on December 30, 2025, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of December 31, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vraylar is a psychiatric medication used in the treatment of schizophrenia and bipolar disorder, reflecting the pharmaceutical supplier's role in supporting military and federal healthcare system medication needs.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies supporting Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal contracts covering specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, positioning the company as a critical vendor for federal medical procurement.
Quick answers
Who was awarded contract SPE2DR26FR05R?
SPE2DR26FR05R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FR05R worth?
The government has obligated $28,611 on SPE2DR26FR05R.
Is contract SPE2DR26FR05R an order under another contract?
Yes. SPE2DR26FR05R is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR05R competed?
The extent of competition for SPE2DR26FR05R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award